Catalyst

Slingshot members are tracking this event:

Alexion Presents New SBC-103 (rhNAGLU enzyme) Phase 1/2 Data on Brain MRI and Neurocognitive Assessments in Patients with Mucopolysaccharidosis IIIB (MPS IIIB)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ALXN

100%

Additional Information

http://ir.alexionpha...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 14, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sbc-103, Rhnaglu Enzyme, Brain Mri, Neurocognitive Assessments, Mucopolysaccharidosis Iiib